ORIC
NASDAQ · Biotechnology
Oric Pharmaceuticals Inc
$12.97
+0.30 (+2.37%)
Open$12.68
Previous Close$12.67
Day High$13.06
Day Low$12.54
52W High$14.93
52W Low$7.23
Volume—
Avg Volume1.31M
Market Cap1.34B
P/E Ratio—
EPS$-1.35
SectorBiotechnology
Analyst Ratings
Strong Buy
20 analysts
Price Target
+302.9% upside
Current
$12.97
$12.97
Target
$52.26
$52.26
$31.55
$52.26 avg
$71.26
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 151.33M | 156.80M | 123.33M |
| Net Income | -16,895,209 | -20,414,835 | -15,522,009 |
| Profit Margin | -11.2% | -13.0% | -12.6% |
| EBITDA | -22,168,918 | -26,679,727 | -20,408,682 |
| Free Cash Flow | -10,591,679 | -9,966,569 | -9,555,180 |
| Rev Growth | +7.8% | +20.1% | +4.2% |
| Debt/Equity | 0.36 | 0.45 | 0.43 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |